Riskpilot← Back to searchSign inGet full accessMedfokus AB
ABActiveOrg 5568410731Fabriksgatan 10Medical specialists activities · NACE 8622Est. 20111-4 employees
Revenue 2024
SEK 2,9M
+31% vs 2023
EBITDA margin
42.2%
+135% vs 2023
Equity ratio
96.4%
Financial strength
Net profit 2024
SEK 900K
-37% vs 2023
| Revenue | SEK 2,9M | +31% |
| EBITDA | SEK 1,2M | +135% |
| Net profit | SEK 900K | -37% |
| Total assets | SEK 4,7M | +8% |
| Equity | SEK 4,5M | +8% |
| Employees | — | — |
Legal name
Medfokus AB
Org number
5568410731
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 februari 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva uthyrning av läkartjänster. Arbeta med medicinsk kompetensutveckling och utbildning.
Address
Fabriksgatan 10
Email
medfokus@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 450 | 2 238 | 2 355 | 2 197 | 2 877 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 942 | 680 | 793 | 517 | 1 215 |
| Depreciation & amort. | −142 | −0 | −0 | −0 | −98 |
| EBIT | 800 | 680 | 793 | 517 | 1 117 |
| Net financials | — | — | 1 | 1 012 | 17 |
| Profit before tax | 799 | 681 | 794 | 1 529 | 1 134 |
| Tax | −172 | −141 | −164 | −109 | −234 |
| Net profit | 627 | 540 | 630 | 1 420 | 900 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 324 | 3 378 | 3 489 | 4 325 | 4 688 |
| Equity | 3 132 | 3 173 | 3 288 | 4 179 | 4 519 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 192 | 205 | 201 | 146 | 169 |
| Total debt | 192 | 205 | 201 | 146 | 169 |
EBITDA margin
42.2%
This company
15.8%
Market median
+167% vs market
20202024
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20202024
Net profit margin
31.3%
This company
8.1%
Market median
+286% vs market
20202024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medfokus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Gert Ove Almgren | Deputy Board Member | 0 companies |
| Frida Eva Anna Almgren | Board of Directors | 0 companies |
| Sonja Eva Anna Almgren | Deputy Board Member | 0 companies |